Your browser doesn't support javascript.
loading
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
Tanaka, Yoshiya; Takahashi, Toshiya; Van Hoogstraten, Hubert; Praestgaard, Amy; Kato, Naoto; Kameda, Hideto.
Affiliation
  • Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. tanaka@med.uoeh-u.ac.jp.
  • Takahashi T; Specialty Care Medical, Sanofi K.K., Tokyo, Japan.
  • Van Hoogstraten H; Global Medical Affairs, Sanofi, Bridgewater, NJ, USA.
  • Praestgaard A; Global Medical Affairs Department of Biostatistics, Sanofi, Cambridge, MA, USA.
  • Kato N; Asahi Kasei Pharma Corporation, Tokyo, Japan.
  • Kameda H; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.
Clin Exp Rheumatol ; 41(5): 1129-1139, 2023 May.
Article in En | MEDLINE | ID: mdl-36305354

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Anemia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Exp Rheumatol Year: 2023 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Anemia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Exp Rheumatol Year: 2023 Document type: Article Affiliation country: Japón